Evidence map›Paper›PMID 20073563›Full record

ReviewThe Australian and New Zealand journal of psychiatry2010

Prevalence estimates of combat-related post-traumatic stress disorder: critical review.

Lisa K Richardson, B Christopher Frueh, Ronald Acierno

Registry-linked trialAbstract readComparative StudyReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Australian and New Zealand journal of psychiatry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06990191 (A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD), which is not on this map. Cited by 176 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
176citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06990191 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD

TypeinterventionalSponsorUnited States Department of DefenseRan2025 to 2028Enrolled420ConditionsPost Traumatic Stress DisorderArmsPartnered Prolonged Exposure (PPE), Prolonged Exposure (PE)
3 · Its place in the literature

Who cites it

176 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2017
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Comparing the effect of prolonged exposure therapy (PET) and metacognitive therapy (MCT) on the quality of life among veterans with PTSD.Military psychology : the official journal of the Division of Military Psychology, American Psychological Association · 2024
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lisa K RichardsonMenninger Clinic, Baylor College of Medicine, 2801 Gessner Drive, Houston, TX 77080, USA.
B Christopher Frueh
Ronald Acierno

Funding

Mentoring/Career Development in PTSD Services ResearchK24MH074468 · NIMH · UNIVERSITY OF HAWAII AT HILO · PI FRUEH, BARTLEY CHRISTOPHER · 2006 to 2010
$745k
NIMH NIH HHS K24 MH074468NIMH NIH HHS MH074468
6 · The paper itself

Abstract

The aim of the present study was to provide a critical review of prevalence estimates of combat-related post-traumatic stress disorder (PTSD) among military personnel and veterans, and of the relevant factors that may account for the variability of estimates within and across cohorts, including methodological and conceptual factors accounting for differences in prevalence rates across nations, conflicts/wars, and studies. MEDLINE and PsycINFO databases were examined for literature on combat-related PTSD. The following terms were used independently and in combinations in this search: PTSD, combat, veterans, military, epidemiology, prevalence. The point prevalence of combat-related PTSD in US military veterans since the Vietnam War ranged from approximately 2% to 17%. Studies of recent conflicts suggest that combat-related PTSD afflicts between 4% and 17% of US Iraq War veterans, but only 3-6% of returning UK Iraq War veterans. Thus, the prevalence range is narrower and tends to have a lower ceiling among combat veterans of non-US Western nations. Variability in prevalence is likely due to differences in sampling strategies; measurement strategies; inclusion and measurement of the DSM-IV clinically significant impairment criterion; timing and latency of assessment and potential for recall bias; and combat experiences. Prevalence rates are also likely affected by issues related to PTSD course, chronicity, and comorbidity; symptom overlap with other psychiatric disorders; and sociopolitical and cultural factors that may vary over time and by nation. The disorder represents a significant and costly illness to veterans, their families, and society as a whole. Further carefully conceptualized research, however, is needed to advance our understanding of disorder prevalence, as well as associated information on course, phenomenology, protective factors, treatment, and economic costs.

Indexed as

AustraliaCanadaHumansMilitary PersonnelPrevalenceStress Disorders, Post-TraumaticUnited KingdomUnited StatesVeteransWarfare

Identifiers

PMID20073563
PMCPMC2891773

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.